Co-Diagnostics Inc (LTS:0A50)
$ 1.24 0.04 (3.33%) Market Cap: 38.61 Mil Enterprise Value: -3.69 Mil PE Ratio: 0 PB Ratio: 0.53 GF Score: 48/100

Q2 2022 Co-Diagnostics Inc Earnings Call Transcript

Aug 11, 2022 / 08:30PM GMT
Release Date Price: $6.51 (-2.14%)
Operator

Good afternoon, and welcome to the Co-Diagnostics Second Quarter 2022 Earnings Conference Call. (Operator Instructions) Please do note that this event is being recorded.

I would now like to turn the conference over to Andrew Benson, Head of Investor Relations. Please go ahead.

Andrew Benson
Co-Diagnostics, Inc. - Head of IR

Thank you. I am Andrew Benson. And joining me this afternoon are members of Co-Diagnostics management team, including Dwight Egan, Chief Executive Officer; and Brian Brown, Chief Financial Officer. We will begin the call with management's prepared remarks and then open up the call to questions from our analysts.

Before we begin, we would like to inform the listeners that certain statements made by Co-Diagnostics during the course of this call may constitute forward-looking statements. Any statement about company expectations, beliefs, plans, objectives, assumptions or future events or performance are forward-looking statements. For example, statements concerning 2022 financial and operational guidance, the development of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot